Loading organizations...
§ Private Profile · Eden Prairie, MN, USA
Medical device company developing therapeutic ultrasound systems for healthcare providers, focused on advanced wound healing and chronic wounds.
Celleration is a medical technology organization that develops and provides the MIST Therapy platform, a therapeutic ultrasound system designed specifically for advanced wound healing applications. The company's core technology utilizes a low-frequency ultrasound mist to stimulate cellular activity and promote tissue repair in patients suffering from severe chronic wounds. Celleration primarily targets healthcare providers, specialized outpatient clinics, and hospital departments focused on wound care and advanced healing treatments. By delivering non-contact acoustic energy directly to the affected tissue bed, the medical system aims to accelerate the natural biological healing process for complex dermatological and vascular conditions. The platform serves as a clinical complement to traditional standard-of-care wound management protocols within the broader medical sector, though its current operational scale is unverified. The organization's founding year and founder names remain undisclosed in public records.
Celleration has raised $8.0M across 1 funding round.
Celleration has raised $8.0M in total across 1 funding round.
Celleration has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Series E in January 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 12, 2011 | $8M Series E | SightLine Partners | — | Announced |
Celleration has raised $8.0M in total across 1 funding round.
Celleration's investors include Sightline Partners.